When to Use Flublok vs Quadrivalent Inactivated Influenza Vaccine
For most adults ≥18 years, either Flublok (recombinant influenza vaccine) or standard quadrivalent inactivated influenza vaccine (IIV4) is acceptable, with no preferential recommendation between them—except for adults ≥65 years who should preferentially receive higher-dose or adjuvanted vaccines (HD-IIV4, RIV4, or aIIV4) over standard-dose options. 1
Primary Indications for Flublok
Severe Egg Allergy (Any Age ≥18 Years)
- Flublok is the definitive choice for patients with severe egg allergy who are ≥18 years old, as it is manufactured without eggs and carries no egg allergy contraindication 2
- This includes patients with anaphylaxis to eggs or any severity of egg hypersensitivity
- For patients with mild egg allergy (hives only), standard IIV4 can be used with precautions, but Flublok eliminates this concern entirely 2
Adults Aged ≥65 Years (Preferential Recommendation)
- ACIP recommends preferential use of higher-dose or adjuvanted vaccines for all adults ≥65 years, which includes quadrivalent recombinant influenza vaccine (RIV4/Flublok Quadrivalent) 1
- The three preferred options are:
- HD-IIV4 (high-dose inactivated, 60 μg HA per strain)
- RIV4 (recombinant, 45 μg HA per strain)
- aIIV4 (MF59-adjuvanted)
- If none of these three vaccines is available, then use any age-appropriate standard-dose IIV4 1
- This preferential recommendation is based on superior immunogenicity and effectiveness data in older adults
Adults Aged 50-64 Years (Evidence-Based Consideration)
- Flublok demonstrated 15.3% higher relative vaccine effectiveness compared to standard-dose IIV4 in adults 50-64 years (95% CI: 5.9-23.8%) against PCR-confirmed influenza 3
- Relative VE against influenza A specifically was 15.7% (95% CI: 6.0-24.5%) 3
- While not a formal preferential recommendation, this represents the highest quality recent evidence (2023, NEJM) showing measurable clinical benefit
- Consider Flublok for this age group when available, particularly during H3N2-predominant seasons
When Standard IIV4 is Equally Appropriate
Adults 18-49 Years Without Egg Allergy
- No preferential recommendation exists between Flublok and standard IIV4 for healthy adults 18-49 years 4
- Head-to-head immunogenicity studies show comparable responses 5
- Safety profiles are similar with mild, transient reactions 5, 6
- Use whichever vaccine is readily available
Immunocompromised Patients
- Both Flublok and IIV4 may have diminished immune responses in immunocompromised individuals 7
- No evidence suggests superiority of one over the other in this population
- The higher antigen content in Flublok (45 μg vs 15 μg HA per strain) theoretically could provide benefit, but this is not established
Key Contraindications and Precautions
Flublok-Specific
- Contraindicated: Severe allergic reaction to any vaccine component (not egg-related) 7
- Precautions:
- Not approved for children <18 years (as of the 2022-23 season; note: 2025 guidelines show expansion to age ≥9 years) 8
Standard IIV4
- Same precautions as Flublok
- Labeled contraindication for severe egg allergy, though ACIP allows use with precautions for mild egg allergy 4
Practical Algorithm for Selection
Step 1: Age Assessment
- Age ≥65 years → Preferentially use Flublok (RIV4), HD-IIV4, or aIIV4; if unavailable, use standard IIV4
- Age 50-64 years → Consider Flublok based on superior effectiveness data; standard IIV4 acceptable
- Age 18-49 years → Either vaccine appropriate
Step 2: Egg Allergy Status
- Severe egg allergy (any age ≥18 years) → Use Flublok
- Mild egg allergy (hives only) → Flublok preferred; standard IIV4 acceptable with precautions
- No egg allergy → Proceed to Step 3
Step 3: Vaccine Availability
- Use whichever appropriate vaccine is immediately available
- Do not delay vaccination waiting for a specific product in adults 18-49 years without egg allergy
Common Pitfalls to Avoid
Do not withhold vaccination from egg-allergic patients thinking no options exist—Flublok is egg-free and safe for severe egg allergy 2
Do not use Flublok in children <18 years during most seasons (check current FDA approvals, as age indication expanded to ≥9 years in 2025) 8, 7
Do not assume all "high-dose" or "enhanced" vaccines are the same—Flublok is recombinant with 45 μg HA per strain, HD-IIV4 has 60 μg, and aIIV4 has standard dose (15 μg) with adjuvant 1
For adults ≥65 years, do not use standard-dose IIV4 if any of the three preferentially recommended vaccines (HD-IIV4, RIV4, aIIV4) are available 1
Do not delay vaccination in July-August for adults ≥65 years if there is concern later vaccination may not occur, despite general recommendation to avoid early vaccination due to waning immunity 8